Stories tagged: Motley Fool
Sun., Sept. 17, 2017
Motley Fool: Investing in investing
As the company behind the popular iShares line of ETFs, BlackRock has reaped huge rewards from investors’ move toward passive investing solutions.
Sun., Sept. 10, 2017
Motley Fool: An Alphabet for all ages
Investors in Alphabet get a dominant online advertising business coupled with the chance that one of the company’s “moonshots” will become the next big thing.
Sun., Sept. 3, 2017
Motley Fool: Balm in Gilead
Rapidly sinking sales of drugs that essentially cure hepatitis C have hammered Gilead Sciences stock (Nasdaq: GILD) so hard you’d think it’s bleeding money. But nothing could be further from …
Sun., Aug. 27, 2017
Motley Fool: Diversified soft drink giant a good defense
Even if the market heads south for a while, PepsiCo investors are still likely to continue enjoying its dividend.
Sun., Aug. 20, 2017
Motley Fool: Growing Amazon will get bigger
How can that be? Well, the e-commerce revolution is just entering its adolescence. E-commerce accounted for only 8.7 percent of the $22 trillion worldwide retail market in 2016. Clearly, there’s …
Sun., Aug. 13, 2017
Motley Fool: Dividend streak makes Target worth a shot
Given that Target is a brick-and-mortar retailer in a world where consumer dollars are shifting online, there’s plenty of justification for pessimism despite the beaten-down valuation. But don’t count Target …
Sun., July 30, 2017
Motley Fool: A pipeline of potential profits
For a hefty pipeline, check out the Swiss pharmaceutical giant Roche. It sports about 150 clinical programs in development, including some for combination treatments based on the company’s already-approved drugs.
Sun., July 23, 2017
Motley Fool: Profits from car parts meaning growth
If you’d like to invest in the auto industry but are worried about disruptions from electric vehicles threatening your investments, consider Copart.
Sun., July 16, 2017
Motley Fool: Rural-focused retailer meets needs of customer base
Shares of rural lifestyle retailer Tractor Supply Co. (Nasdaq: TSCO) were recently down 43 percent from their 52-week high, giving investors a chance to buy a piece of the industry …
Sun., July 9, 2017
The Motley Fool: Big-name brands can win even if stores fail
VF Corp. – owner of North Face jackets, Timberland boots, Smartwool socks, Vans shoes and more – is worth considering for your portfolio.
Sun., July 2, 2017
Motley Fool: Forecast good for Seagate Tech dividends, earnings
Seagate Technology’s stock may not seem bargain-priced with its recent price-to-earnings ratio of 17, but analysts expect strong growth, with earnings more than doubling over the coming five years
Sun., June 25, 2017, 5 a.m.
Motley Fool: Lowe’s provides something to build on
The home-improvement retail chain has increased its dividend payouts without fail in each of the last 54 years. Lowe’s annual payouts have more than doubled over the last four years …
Sun., June 18, 2017, 2 a.m.
Motley Fool: General Motors deserves test drive
Many investors are anticipating the spread of electric cars and self-driving vehicles and assuming that the traditional automakers are toast. General Motors’ (NYSE: GM) CEO Mary Barra sees it differently.
Sun., June 11, 2017, 3 a.m.
Motley Fool: Its non-refining interests make Phillips 66 worth a look
Its businesses of chemicals, midstream, and marketing and specialties have kept it in the green during the refining sector’s recent challenges, and those segments hold the company’s most compelling growth …
Sun., June 4, 2017, 3 a.m.
Motley Fool: Healthy prospects for ‘rebuilding’ CVS Health
CVS has a major tailwind in the ongoing aging of America, which will only increase demand for its services.
Sun., May 28, 2017
Motley Fool: Still growing Facebook looks good for long-term investment
Facebook’s price-to-earnings ratio, recently near 40, may seem high, but given the company’s growth rate and growth potential, the stock seems like a promising candidate for a long-term portfolio.
Sun., May 21, 2017, 6 a.m.
Motley Fool: Documented profits for Iron Mountain
Iron Mountain’s (NYSE: IRM) core business is providing storage, primarily of records, and information management services to companies and government organizations. It’s also been expanding into related operations, such as …
Sun., May 14, 2017, 6:40 a.m.
Motley Fool: Whirlpool should appeal to value investors
Whirlpool (NYSE: WHR), the largest appliance manufacturer in the world, is trading at an appealing price for long-term investors. After years of growth, the company has experienced a few hiccups …
Sun., May 7, 2017, 6:30 a.m.
Motley Fool: Long-term success of mutual funds for T. Rowe Price
One of the world’s largest mutual fund companies, T. Rowe Price’s (Nasdaq: TROW) long history of excellence has made its own shares a winning investment. They have risen by about …
Sun., April 30, 2017, 4:02 a.m.
Motley Fool: Starbucks stock poised to perk up
Starbucks’ (Nasdaq: SBUX) stock has been a dud for investors over the past year. That has some wanting to exit the coffeehouse, but they will likely do well to stick …
Sun., April 23, 2017, 5:12 a.m.
Motley Fool: McKesson well positioned for profitability
It rakes in close to $200 billion per year, employs about 70,000 people and is No. 5 on the Fortune 500 list, but relatively few people have heard of McKesson …
Sun., April 16, 2017, 6 a.m.
Motley Fool: A buying opportunity in Hanesbrands
Just about every consumer has purchased something from Hanesbrands (NYSE: HBI), with its well-established brands that include Hanes, Champion, Maidenform, DIM, Bali, Playtex, Bonds, JMS/Just My Size, Nur Die/Nur Der, …
Sun., April 9, 2017, 4:30 a.m.
Motley Fool: The money mouse: Disney’s deep portfolio
With blockbuster movies like “Captain America: Civil War” and “Zootopia,” studios helped Disney rake in more than $7.5 billion in total box-office receipts last year.
Sun., April 2, 2017
The Motley Fool: Pfizer’s drug pipeline is an envious mix fighting heart disease, cancer and diabetes and others
There’s lots to like about Pfizer these days.
Sun., March 26, 2017
Motley Fool: Biotech company AbbVie offers healthy dividends
One of the best health care dividend stocks around belongs to biotech company AbbVie (NYSE: ABBV), which was spun off by Abbott Laboratories in 2013.
Sun., March 19, 2017
Motley Fool: Footwear giant Nike more than just sneakers
Shares of global footwear and apparel giant Nike (NYSE: NKE) were recently down about 13 percent from their 52-week highs. That spells opportunity more than trouble.
Sun., March 12, 2017
Motley Fool: General Electric’s bright future
Not all that long ago, General Electric (NYSE: GE) was a mega-conglomerate with its hands in a wide variety of businesses. Not anymore.
Sun., March 5, 2017
Motley Fool: Ford Motor churning out cars, profits
Ford Motor Co. (NYSE: F) has made vast improvements in the quality and attractiveness of its vehicles since the recession subsided, and now it’s churning out profits quarter after quarter. …
Sun., Feb. 26, 2017
Motley Fool: AMC down, but don’t count it out
Shares of AMC Networks (Nasdaq: AMCX), the network behind the hit show “The Walking Dead,” has acted somewhat zombielike, falling 30 percent in 2016 – and drawing the attention of …
Sun., Feb. 19, 2017
Motley Fool: Look to biotech sector for undervalued stocks
With the stock market trading near an all-time high, it’s hard to find undervalued stocks. You can find some in the biotechnology sector, though. Consider Celgene (Nasdaq: CELG).